Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001081469 | SCV000289548 | likely benign | Brugada syndrome | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000231917 | SCV001795912 | likely benign | not provided | 2020-09-24 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002392710 | SCV002702787 | likely benign | Cardiovascular phenotype | 2019-11-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002487079 | SCV002802255 | likely benign | Episodic pain syndrome, familial, 2 | 2021-09-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005238765 | SCV005883862 | likely benign | not specified | 2024-12-03 | criteria provided, single submitter | clinical testing | Variant summary: SCN10A c.1430C>T (p.Pro477Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00052 in 251480 control chromosomes, predominantly at a frequency of 0.00091 within the Non-Finnish European subpopulation in the gnomAD database. The allele frequency suggests that the variant is likely not associated with high a penetrance, severe, dominant disease phenotype. To our knowledge, no occurrence of c.1430C>T in individuals affected with Episodic pain syndrome, familial, 2 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 240663). Based on the evidence outlined above, the variant was classified as likely benign. |
Clinical Genetics, |
RCV000231917 | SCV001917316 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000231917 | SCV001959307 | likely benign | not provided | no assertion criteria provided | clinical testing |